New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.
We combine professionalism, state of the art knowledge and friendliness to assure that you will receive superb service in a timely manner.
2024 © All Rights Reserved. Privacy Policy